ClinVar Miner

Submissions for variant NM_212482.4(FN1):c.6721G>A (p.Val2241Ile)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Fulgent Genetics, Fulgent Genetics RCV005023672 SCV005648919 uncertain significance Glomerulopathy with fibronectin deposits 2; Spondylometaphyseal dysplasia - Sutcliffe type 2023-12-21 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV005103744 SCV005767134 likely benign not provided 2024-07-03 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004747869 SCV005348365 uncertain significance FN1-related disorder 2024-03-28 no assertion criteria provided clinical testing The FN1 c.6721G>A variant is predicted to result in the amino acid substitution p.Val2241Ile. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0062% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.